AMANDA TATLER AMANDA.TATLER@NOTTINGHAM.AC.UK
Principal Research Fellow
Reduced Ets domain-containing protein Elk1 promotes pulmonary fibrosis via increased integrin ?v?6 expression
Tatler, Amanda L.; Habgood, Anthony; Porte, Joanne; John, Alison E.; Stavrou, Anastasios; Hodge, Emily; Kerama-Likoko, Cheryl; Violette, Shelia M.; Weinreb, Paul H.; Knox, Alan J.; Laurent, Geoffrey; Parfrey, Helen; Wolters, Paul John; Wallace, William; Alberti, Siegfried; Nordheim, Alfred; Jenkins, Gisli
Authors
Anthony Habgood
Joanne Porte
Alison E. John
Anastasios Stavrou
Emily Hodge
Cheryl Kerama-Likoko
Shelia M. Violette
Paul H. Weinreb
Alan J. Knox
Geoffrey Laurent
Helen Parfrey
Paul John Wolters
William Wallace
Siegfried Alberti
Alfred Nordheim
Gisli Jenkins
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with high mortality. Active TGF?1 is considered central to the pathogenesis of IPF. A major mechanism of TGF?1 activation in the lung involves the epithelially restricted ?v?6 integrin. Expression of the ?v?6 integrin is dramatically increased in IPF. How ?v?6 integrin expression is regulated in the pulmonary epithelium is unknown. Here we identify a region in the ?6 subunit gene (ITGB6) promoter acting to markedly repress basal gene transcription, which responds to both the Ets domain-containing protein Elk1 (Elk1) and the glucocorticoid receptor (GR). Both Elk1 and GR can regulate ?v?6 integrin expression in vitro. We demonstrate Elk1 binding to the ITGB6 promoter basally and that manipulation of Elk1 or Elk1 binding alters ITGB6 promoter activity, gene transcription, and ?v?6 integrin expression. Crucially, we find that loss of Elk1 causes enhanced Itgb6 expression and exaggerated lung fibrosis in an in vivo model of fibrosis, whereas the GR agonist dexamethasone inhibits Itgb6 expression. Moreover, Elk1 dysregulation is present in epithelium from patients with IPF. These data reveal a novel role for Elk1 regulating ITGB6 expression and highlight how dysregulation of Elk1 can contribute to human disease.
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 9, 2016 |
Online Publication Date | Feb 11, 2016 |
Publication Date | Apr 29, 2016 |
Deposit Date | Aug 17, 2018 |
Publicly Available Date | Jan 22, 2019 |
Print ISSN | 0021-9258 |
Publisher | American Society for Biochemistry and Molecular Biology |
Peer Reviewed | Peer Reviewed |
Volume | 291 |
Issue | 18 |
Pages | 9540-9553 |
DOI | https://doi.org/10.1074/jbc.M115.692368 |
Public URL | https://nottingham-repository.worktribe.com/output/1113317 |
Publisher URL | http://www.jbc.org/content/291/18/9540 |
PMID | 26861876 |
Files
J. Biol. Chem.-2016-Tatler-9540-53
(2.9 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy
(2018)
Journal Article
Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis
(2016)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search